Home / Blog
Global Blood Collection Tubes Revenue For Liquid Biopsy Is Nearly 13 K USD In 2018
Wednesday, 06 May, 2020
The blood collection tubes for liquid biopsy is a direct-draw tube for the collection, stabilization and transportation of whole blood specimens. It effectively prevents blood coagulation, prevents cell analysis and preserves nucleated cells to enable efficient analysis of cell-free DNA (cfDNA). A blood collection tube which stabilizes nucleated blood cells. The unique preservative prevents the release of genomic DNA, allowing isolation of high-quality cell-free DNA.

In the last several years, global market of Blood Collection Tubes for Liquid Biopsy developed rapidly, with an average growth rate of 28.51% during 2014 to 2018. In 2018, global revenue of Blood Collection Tubes for Liquid Biopsy is nearly 13 K USD; the actual production is about 2775 thousand units.

The global average price of Blood Collection Tubes for Liquid Biopsy is in the decreasing trend, from 4.44 USD/Unit in 2012 to 4.41 USD/Unit in 2018. With the situation of global economy, prices will be in decreasing trend in the following five years.

The classification of Blood Collection Tubes for glass and plastic type. The proportion of plastic in 2018 is about 92.88%, and the proportion of glass type in 2018 is about 7.12%. 

Blood Collection Tubes for Liquid Biopsy is application in IVD and research use. The most of Blood Collection Tubes for Liquid Biopsy is used in IVD, and the market share in 2018 is about 76.95%. 

Europe is the largest supplier of Blood Collection Tubes for Liquid Biopsy, with a production market share nearly 52.14% in 2018. North America is the second largest supplier of Blood Collection Tubes for Liquid Biopsy, enjoying production market share about 45.8% in 2018.

North America is the largest consumption place, with a consumption market share nearly 54.05% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 25.21% in 2018.

Roche, Streck, Preanalytix, Norgen Biotek and Bioceptare are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.